FDA Calls GSK's Avandia Safe Amid Public Concerns
On the heels of senators blasting the U.S. Food and Drug Administration for its purportedly lax regulation of the GlaxoSmithKline PLC drug Avandia, the agency has published a safety announcement telling...To view the full article, register now.
Already a subscriber? Click here to view full article